Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 5
2005 3
2006 9
2007 13
2008 32
2009 37
2010 21
2011 21
2012 28
2013 30
2014 35
2015 19
2016 30
2017 27
2018 21
2019 17
2020 23
2021 17
2022 14
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Results by year

Filters applied: . Clear all
Page 1
Targeting m6A binding protein YTHDFs for cancer therapy.
Zhang W, Wu T, Zhang Y, Kang W, Du C, You Q, Chen X, Jiang Z. Zhang W, et al. Among authors: you q. Bioorg Med Chem. 2023 Jul 15;90:117373. doi: 10.1016/j.bmc.2023.117373. Epub 2023 Jun 12. Bioorg Med Chem. 2023. PMID: 37329678 Review.
p62 as a therapeutic target for tumor.
Tao M, Liu T, You Q, Jiang Z. Tao M, et al. Among authors: you q. Eur J Med Chem. 2020 May 1;193:112231. doi: 10.1016/j.ejmech.2020.112231. Epub 2020 Mar 17. Eur J Med Chem. 2020. PMID: 32193054 Review.
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope.
Ma S, Ji J, Tong Y, Zhu Y, Dou J, Zhang X, Xu S, Zhu T, Xu X, You Q, Jiang Z. Ma S, et al. Among authors: you q. Acta Pharm Sin B. 2022 Jul;12(7):2990-3005. doi: 10.1016/j.apsb.2022.02.022. Epub 2022 Feb 26. Acta Pharm Sin B. 2022. PMID: 35865099 Free PMC article. Review.
G9a - An Appealing Antineoplastic Target.
Chen WL, Sun HP, Li DD, Wang ZH, You QD, Guo XK. Chen WL, et al. Curr Cancer Drug Targets. 2017;17(6):555-568. doi: 10.2174/1568009616666160512145303. Curr Cancer Drug Targets. 2017. PMID: 27174055 Review.
An updated patent review of Nrf2 activators (2020-present).
Zhao Z, Dong R, Cui K, You Q, Jiang Z. Zhao Z, et al. Among authors: you q. Expert Opin Ther Pat. 2023 Jan;33(1):29-49. doi: 10.1080/13543776.2023.2178299. Epub 2023 Feb 18. Expert Opin Ther Pat. 2023. PMID: 36800917 Review.
379 results